Pricing and access are now becoming central to the competitive narrative
26 DISCUSSION The use of weight loss medications, particularly GLP-1 RAs, is increasing steadily, both with and without medical supervision
While mild episodes may not be life threatening, continued ventricular tachycardia that lasts for more than a few seconds is dangerous and may evolve into ventricular fibrillation, which can be fatal (Hebbar 2002a
Originally developed to manage diabetes, these medications began showing significant weight reduction in clinical trials
Key findings from body composition studies include: Visceral fat (the deep abdominal fat surrounding organs) decreases alongside subcutaneous fat Studies suggest that approximately 60-75% of weight loss comes from fat mass, with the remainder from lean tissue [17] [18] Waist circumferencea proxy measure for abdominal obesitytypically reduces by 6-10 cm on average in clinical trials [8] [9] Improvements in metabolic parameters often occur alongside reductions in visceral fat It is worth noting that individual responses vary considerably
If you need long-term prokinetic therapy, GLP-1 medications might not be the best fit